Ignite Creation Date:
2025-12-24 @ 4:31 PM
Ignite Modification Date:
2026-01-27 @ 4:49 PM
Study NCT ID:
NCT00042666
Status:
COMPLETED
Last Update Posted:
2020-08-10
First Post:
2002-08-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Oral LY317615 in Relapsed or Refractory Diffuse Large B-Cell Lymphomas.
Sponsor:
Eli Lilly and Company
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Non-Hodgkin's Lymphoma | View |
Keywords: